RGEN

REPLIGEN CORP

Healthcare | Mid Cap

$0.35

EPS Forecast

$153.9

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2024-12-31
NBIXNeurocrine Biosciences IncTECHBio-techne CorpHALOHalozyme Therapeutics IncCRSPCrispr Therapeutics AgDNLIDenali Therapeutics IncIOVAIovance Biotherapeutics IncMRNAModerna IncNVAXNovavax IncREPLReplimune Group Inc